Literature DB >> 29633114

The Prognostic Value of Varying Definitions of Positive Resection Margin in Patients with Colorectal Cancer Liver Metastases.

Jane Wang1, Georgios Antonios Margonis1, Neda Amini1, Nikolaos Andreatos1, Chunhui Yuan1, Christos Damaskos2, Efstathios Antoniou2, Nikolaos Garmpis2, Stefan Buettner1, Carlotta Barbon1, Amar Deshwar1, Jin He1, Richard Burkhart1, Timothy M Pawlik1, Christopher L Wolfgang1, Matthew J Weiss3,4.   

Abstract

BACKGROUND: Varying definitions of resection margin clearance are currently employed among patients with colorectal cancer liver metastases (CRLM). Specifically, a microscopically positive margin (R1) has alternatively been equated with an involved margin (margin width = 0 mm) or a margin width < 1 mm. Consequently, patients with a margin width of 0-1 mm (sub-mm) are inconsistently classified in either the R0 or R1 categories, thus obscuring the prognostic implications of sub-mm margins.
METHODS: Six hundred thirty-three patients who underwent resection of CRLM were identified. Both R1 definitions were alternatively employed and multivariable analysis was used to determine the predictive power of each definition, as well as the prognostic implications of a sub-mm margin.
RESULTS: Five hundred thirty-nine (85.2%) patients had a margin width ≥ 1 mm, 42 had a sub-mm margin width, and 52 had an involved margin (0 mm). A margin width ≥ 1 mm was associated with improved survival vs. a sub-mm margin (65 vs. 36 months; P = 0.03) or an involved margin (65 vs. 33 months; P < 0.001). No significant difference in survival was detected between patients with involved vs. sub-mm margins (P = 0.31). A sub-mm margin and an involved margin were both independent predictors of worse OS (HR 1.66, 1.04-2.67; P = 0.04, and HR 2.14, 1.46-3.16; P < 0.001, respectively) in multivariable analysis. Importantly, after combining the two definitions, patients with either an involved margin or a sub-mm margin were associated with worse OS in multivariable analysis (HR 1.94, 1.41-2.65; P < 0.001).
CONCLUSIONS: Patients with involved or sub-mm margins demonstrated a similar inferior OS vs. patients with a margin width > 1 mm. Consequently, a uniform definition of R1 as a margin width < 1 mm should perhaps be employed by future studies.

Entities:  

Keywords:  CRLM; Margin definition; Resection margin

Mesh:

Year:  2018        PMID: 29633114     DOI: 10.1007/s11605-018-3748-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  34 in total

1.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

2.  Impact of margin status and neoadjuvant chemotherapy on survival, recurrence after liver resection for colorectal liver metastasis.

Authors:  Sanjay Pandanaboyana; Alan White; Samir Pathak; Ernest L Hidalgo; Giles Toogood; J P Lodge; K R Prasad
Journal:  Ann Surg Oncol       Date:  2014-08-02       Impact factor: 5.344

3.  Critical review of the prognostic significance of pathological variables in patients undergoing resection for colorectal liver metastases.

Authors:  Dhanwant Gomez; Abed M Zaitoun; Antonella De Rosa; Sina Hossaini; Ian J Beckingham; Adam Brooks; Iain C Cameron
Journal:  HPB (Oxford)       Date:  2014-03-12       Impact factor: 3.647

4.  Effect of subcentimeter nonpositive resection margin on hepatic recurrence in patients undergoing hepatectomy for colorectal liver metastases. Evidences from 663 liver resections.

Authors:  J Figueras; F Burdio; E Ramos; J Torras; L Llado; S Lopez-Ben; A Codina-Barreras; S Mojal
Journal:  Ann Oncol       Date:  2007-04-13       Impact factor: 32.976

5.  KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.

Authors:  Georgios A Margonis; Kazunari Sasaki; Nikolaos Andreatos; Yuhree Kim; Katiuscha Merath; Doris Wagner; Ana Wilson; Stefan Buettner; Neda Amini; Efstathios Antoniou; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-09-30       Impact factor: 5.344

Review 6.  The importance of surgical margins in primary malignancies of the liver.

Authors:  Kelly Lafaro; Miral Sadaria Grandhi; Joseph M Herman; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2015-12-10       Impact factor: 3.454

7.  Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Authors:  Eran Sadot; Bas Groot Koerkamp; Julie N Leal; Jinru Shia; Mithat Gonen; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; Nancy Kemeny; Leslie H Blumgart; William R Jarnagin; Michael I DʼAngelica
Journal:  Ann Surg       Date:  2015-09       Impact factor: 12.969

8.  Appraisal of 1 cm hepatectomy margins for intrahepatic micrometastases in patients with colorectal carcinoma liver metastasis.

Authors:  Toshifumi Wakai; Yoshio Shirai; Jun Sakata; Vladimir A Valera; Pavel V Korita; Kouhei Akazawa; Yoichi Ajioka; Katsuyoshi Hatakeyama
Journal:  Ann Surg Oncol       Date:  2008-07-02       Impact factor: 5.344

9.  Resection of colorectal liver metastases: is a resection margin of 3 mm enough? : a multicenter analysis of the GAST Study Group.

Authors:  Ralf Konopke; Stephan Kersting; Frank Makowiec; Peter Gassmann; Eberhard Kuhlisch; Norbert Senninger; Ulrich Hopt; Hans Detlev Saeger
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

10.  Surgery for colorectal liver metastases: the impact of resection margins on recurrence and overall survival.

Authors:  Jon-Helge Angelsen; Arild Horn; Geir Egil Eide; Asgaut Viste
Journal:  World J Surg Oncol       Date:  2014-04-27       Impact factor: 2.754

View more
  5 in total

1.  Colorectal cancer liver metastases within the central and peripheral segments: Parenchymal sparing surgery adaptation.

Authors:  A A Burlaka; A V Paliichuk; O I Iatsyna; О О Kolesnik
Journal:  Ann Med Surg (Lond)       Date:  2020-08-14

2.  Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases.

Authors:  Ulf Kulik; Mareike Plohmann-Meyer; Jill Gwiasda; Joline Kolb; Daniel Meyer; Alexander Kaltenborn; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  HPB Surg       Date:  2018-10-21

3.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

4.  Two-Stage Hepatectomy for Bilateral Colorectal Liver Metastases: A Multi-institutional Analysis.

Authors:  Mariana I Chavez; Sepideh Gholami; Bradford J Kim; Georgios A Margonis; Cecilia G Ethun; Susan Tsai; Kathleen K Christians; Callisia Clarke; Harveshp Mogal; Shishir K Maithel; Timothy M Pawlik; Michael I D'Angelica; Thomas A Aloia; Daniel Eastwood; T Clark Gamblin
Journal:  Ann Surg Oncol       Date:  2021-01-03       Impact factor: 5.344

5.  Systemic Therapy and Its Surgical Implications in Patients with Resectable Liver Colorectal Cancer Metastases. A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.

Authors:  Shahid Ahmed; Nicholas Bosma; Michael Moser; Shahida Ahmed; Bryan Brunet; Janine Davies; Corinne Doll; Dorie-Anna Dueck; Christina A Kim; Shuying Ji; Duc Le; Richard Lee-Ying; Howard Lim; John Paul McGhie; Karen Mulder; Jason Park; Deepti Ravi; Daniel J Renouf; Devin Schellenberg; Ralph P W Wong; Adnan Zaidi
Journal:  Curr Oncol       Date:  2022-03-08       Impact factor: 3.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.